JP Morgan Chase
SHC icon

JP Morgan Chase’s Sotera Health SHC Stock Holding History

JP Morgan Chase’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,400
Closed -$23.4K – 7695
2024
Q3 		$23.4K Buy
+1,400
New +$20.5K ﹤0.01% 6201

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase's SHC Position: Q1 2026 in Review

JP Morgan Chase reduced its Sotera Health (SHC) stake by 0.95% in Q1 2026, selling an estimated $45.3K and leaving 282,963 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

JP Morgan Chase first reported a position in SHC in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.04M in Q4 2025. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • JP Morgan Chase held 282,963 shares of Sotera Health worth $3.75M as of Q1 2026.
  • JP Morgan Chase sold 2,728 Sotera Health shares in Q1 2026, an estimated $45.3K.
  • Sotera Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3593 holding.
  • JP Morgan Chase first reported a position in Sotera Health in Q4 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's Sotera Health position peaked at $5.04M in Q4 2025.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.